Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Cash from Financing Activities (2020 - 2025)

Candel Therapeutics' Cash from Financing Activities history spans 4 years, with the latest figure at -$121000.0 for Q4 2023.

  • On a quarterly basis, Cash from Financing Activities fell 436.11% to -$121000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was -$121000.0, a 100.61% decrease, with the full-year FY2025 number at $56.1 million, down 40.5% from a year prior.
  • Cash from Financing Activities hit -$121000.0 in Q4 2023 for Candel Therapeutics, down from $36000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for CADL hit a ceiling of $71.4 million in Q3 2021 and a floor of -$121000.0 in Q4 2023.
  • Historically, Cash from Financing Activities has averaged $11.5 million across 4 years, with a median of $74000.0 in 2021.
  • Biggest five-year swings in Cash from Financing Activities: surged 17682.14% in 2022 and later plummeted 436.11% in 2023.
  • Tracing CADL's Cash from Financing Activities over 4 years: stood at $29000.0 in 2020, then soared by 245951.72% to $71.4 million in 2021, then crashed by 99.95% to $36000.0 in 2022, then plummeted by 436.11% to -$121000.0 in 2023.
  • Business Quant data shows Cash from Financing Activities for CADL at -$121000.0 in Q4 2023, $36000.0 in Q4 2022, and $22000.0 in Q2 2022.